UK guidelines for glaucoma treatment make significant change
The National Institute for Health and Care Excellences announced SLT as the new primary form of glaucoma intervention.
Heru reaches clinical milestone: 10,000 patient eyes examined with AR/VR platform
With its portable capabilities, the Heru platform replaces legacy diagnostic devices and surpasses standard care in cost and size.
Poll results: What is your big goal for 2022?
See our latest poll results
Transitions Optical announces new Transitions Academy 2022 dates
Originally postponed due to COVID-19, the annual event will now be held this June at the JW Marriott Grande Lakes in Orlando, Florida.
X-Ide releases new eyewear collection
The new line features diamond coated frames
Orasis Pharmaceuticals completes phase 3 trials for presbyopia candidate
CSF-1 is a preservative-free solution designed as an alternative to reading glasses for patients.
SECO 2022 in review: findings presented in New Orleans
SECO hosted its 2022 annual meeting March 9-13 at the Ernest N. Morial Convention Center with a LIVE CE virtual meeting available to online attendees.
New optical lens coating is ‘self-cleaning’ and anti-fogging
Breakthrough film technology stops lenses from fogging faster than the blink of an eye
Glaukos launches phase 2 corneal health clinical program for iLink therapy
The company expects to enroll patients diagnosed with keratoconus in two trials at clinical sites in the US, South America, Europe, and Asia.
Topcon introduces SOLOS Automatic Lens Analyzer
SOLOS is automatic lens analyzer that enables advanced, accurate, and efficient lens analysis with one button touch.
Effective treatments for presbyopia, myopia, demodex
Pipeline treatments for presbyopia, myopia, and demodex are expanding rapidly
Augmenting corneal thickness with FDA-approved hypotonic riboflavin
Daniel Fuller, OD, FAAO Dipl., FSLS, discusses augmenting corneal thickness in thin keratoconus corneas during corneal cross-linking via FDA-approved hypotonic riboflavin during SECO 2022.
ASCO, Johnson & Johnson Vision partner for more diversity in optometry
The unique partnership and corresponding sponsorship is the largest in ASCO’s history.
Retina news: What's hot (and not)
Mohammad Rafieetary, OD, FAAO, offers a sneak peek at the latest (and fake!) news in retina.
Interventional glaucoma management: The art and science
Lee Peplinski, OD, FAAO, emphasizes the importance of interventional care in patients with glaucoma.
Poll: What is your biggest frustration with optometry as a whole?
Check out our latest poll!
Focus on amblyopia, thyroid eye disease, and papilledema
Clinical pearls on amblyopia, thyroid eye disease, and papilledema treatments from SECO 2022.
Focusing on giant cell arteritis and optic neuritis
Clinical pearls on giant cell arteritis (GCA) and optic neuritis
Combatting dry eye during contact lens wear
Tools and therapies for dry eye with contact lens wear
Amblyopia management: A new paradigm
Robert Sanet, OD, explains the new paradigm in amblyopia, or lazy eye, management
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "New optical lens coating is ‘self-cleaning’ and anti-fogging")
